Tag: NYSE:ABBV

Finance

Trending Tickers : AbbVie Inc. (NYSE:ABBV), JDS Uniphase Corporation (NASDAQ:JDSU), Aviat Networks, Inc. (NASDAQ:AVNW), Alamos Gold Inc. (NYSE:AGI), Cambrex Corporation. (NYSE:CBM),

AbbVie (NASDAQ:ABBV) stock had its “neutral” rating restated by Zacks in a report issued on Monday. They currently have a $61.00 price objective on the stock. Zacks‘s price objective indicates a potential upside of 5.30% from the company’s current price. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 21.70% and weekly performance is 2.90%. On last trading day company shares ended … Continue reading Trending Tickers : AbbVie Inc. (NYSE:ABBV), JDS Uniphase Corporation (NASDAQ:JDSU), Aviat Networks, Inc. (NASDAQ:AVNW), Alamos Gold Inc. (NYSE:AGI), Cambrex Corporation. (NYSE:CBM),

Mark DeFrance
Finance

Shining on Major News : Annaly Capital Management (NYSE:NLY), AbbVie Inc. (NYSE:ABBV), Methes Energies International Ltd. (NASDAQ:MEIL), MICROS (NASDAQ:MCRS), Equity One (NYSE:EQY)

On 27 Aug 2014 Shares of Annaly Capital Management (NYSE:NLY) were the recipient of some unusual options trading on Wednesday. Stock investors acquired 8,328 call options on the company, American Banking and Market News reports. This is an increase of approximately 382% compared to the typical daily volume of 1,727 call options. Annaly Capital Management, Inc. (NYSE:NLY) belongs to Financial sector. Its net profit margin is 42.50% … Continue reading Shining on Major News : Annaly Capital Management (NYSE:NLY), AbbVie Inc. (NYSE:ABBV), Methes Energies International Ltd. (NASDAQ:MEIL), MICROS (NASDAQ:MCRS), Equity One (NYSE:EQY)

Kristen Barton
Finance

Investor’s Pick: Colonial Financial Services (NASDAQ:COBK), Liberty Global (NASDAQ:LBTYA), American Homes 4 Rent (NYSE:AMH), AbbVie Inc. (NYSE:ABBV), Hawaiian Electric Industries (NYSE:HE)

Cape Bancorp (CBNJ) and Colonial Financial Services, Inc. (NASDAQ:COBK) jointly announce they have entered into an agreement and plan of merger under which each shareholder of Colonial, subject to potential adjustments at closing, will be entitled to elect to receive either $14.50 per share in cash or 1.412 shares of Cape’s common stock, subject to 50% of the shares being exchanged for stock and 50% … Continue reading Investor’s Pick: Colonial Financial Services (NASDAQ:COBK), Liberty Global (NASDAQ:LBTYA), American Homes 4 Rent (NYSE:AMH), AbbVie Inc. (NYSE:ABBV), Hawaiian Electric Industries (NYSE:HE)

Kevin Long
Finance

Market Movers: AbbVie Inc. (NYSE:ABBV), Xerox Corporation (NYSE:XRX), SunTrust Banks (NYSE:STI), Danaher Corp. (NYSE:DHR), Eagle Bancorp Montana, Inc. (NASDAQ:EBMT)

AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 21.70% and weekly performance is 1.16%. On last trading day company shares ended up $55.60. AbbVie Inc. (NYSE:ABBV) distance from 50-day simple moving average (SMA50) is 2.25%. One such investor is Robert Zapfel. He is the President of Services Business at Xerox Corp. (NYSE:XRX). On Augusts 7th, Mr. Zapfel bought 40,000 XRX shares at … Continue reading Market Movers: AbbVie Inc. (NYSE:ABBV), Xerox Corporation (NYSE:XRX), SunTrust Banks (NYSE:STI), Danaher Corp. (NYSE:DHR), Eagle Bancorp Montana, Inc. (NASDAQ:EBMT)

Jason Knox
Finance

Eye Catching Stocks: AbbVie Inc. (NYSE:ABBV), DepoMed Inc. (NASDAQ:DEPO), Misonix Inc. (NASDAQ:MSON), Bebe Stores, Inc. (NASDAQ:BEBE)

AbbVie (NASDAQ:ABBV) had its target price boosted by Credit Suisse from $60.00 to $63.00 in a report issued on Wednesday. They currently have an outperform rating on the stock.AbbVie Inc. (NYSE:ABBV) shares moved down -0.21% in last trading session and ended the day at $55.75. ABBV Gross Margin is 76.40% and its return on assets is 14.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 3.89%. DepoMed Inc. … Continue reading Eye Catching Stocks: AbbVie Inc. (NYSE:ABBV), DepoMed Inc. (NASDAQ:DEPO), Misonix Inc. (NASDAQ:MSON), Bebe Stores, Inc. (NASDAQ:BEBE)

Kristen Barton
BioTech, Finance

Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Goldman Sachs has been hired by Shire as the London-listed drug maker confronts a takeover offer, as explained in the Financial Times morning briefing. Shire turned down a $46 billion bid from Chicago-based AbbVie last week. According to a report from the New-York Times, people briefed on the matter said AbbVie was likely to come back with a higher offer. Allergan, which is fending off … Continue reading Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Harvey Dyer